|
|
|
|
|
|
|
||||
|
||||||||||||
|
Sorafenib (Nexavar, BAY 43-9006) : Bayer/Onyx : Oral cystostatic Raf kinase inhibitorSorafenib (Nexavar, BAY 43-9006) - Recent MEDLINE Abstracts (PubMed) Sorafenib (Nexavar, BAY 43-9006)- Clinical Trials (ClinicalTrials.com)
|
|
||||||||||
|
||||||||||||
|
|
|
Copyright © 1999-2006, Lung Cancer Online Foundation Last modified: 26-Apr-2011 Karen Parles, MLS Editor |
